Predictors of the Use of Mineralocorticoid Receptor Antagonists in Patients With Left Ventricular Dysfunction Post‐ST‐Segment–Elevation Myocardial Infarction

BACKGROUND: Guidelines recommend mineralocorticoid receptor antagonist (MRA) use in patients with left ventricular ejection fraction ≤40% following a myocardial infarction plus heart failure or diabetes mellitus, based on mortality benefit in the EPHESUS (Eplerenone Post‐Acute Myocardial Infarction...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Eric C., Fordyce, Christopher B., Wong, Graham, Lee, Terry, Perry‐Arnesen, Michele, Mackay, Martha, Singer, Joel, Cairns, John A., Turgeon, Ricky D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483484/
https://www.ncbi.nlm.nih.gov/pubmed/34227405
http://dx.doi.org/10.1161/JAHA.120.019167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483484/
https://www.ncbi.nlm.nih.gov/pubmed/34227405
http://dx.doi.org/10.1161/JAHA.120.019167

Ejemplares similares